IndexIQ Advisors’s Myriad Genetics MYGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $398K | Buy |
15,792
+1,923
| +14% | +$48.5K | 0.01% | 732 |
|
2021
Q4 | $383K | Sell |
13,869
-896
| -6% | -$24.7K | 0.01% | 813 |
|
2021
Q3 | $477K | Buy |
14,765
+1,479
| +11% | +$47.8K | 0.02% | 596 |
|
2021
Q2 | $406K | Sell |
13,286
-478
| -3% | -$14.6K | 0.01% | 687 |
|
2021
Q1 | $419K | Sell |
13,764
-872
| -6% | -$26.5K | 0.01% | 457 |
|
2020
Q4 | $289K | Buy |
14,636
+1,511
| +12% | +$29.8K | 0.01% | 701 |
|
2020
Q3 | $171K | Buy |
13,125
+712
| +6% | +$9.28K | 0.01% | 771 |
|
2020
Q2 | $141K | Sell |
12,413
-480
| -4% | -$5.45K | 0.01% | 804 |
|
2020
Q1 | $184K | Buy |
+12,893
| New | +$184K | 0.01% | 595 |
|